How can I determine cardiac output in a patient receiving veno‑arterial extracorporeal membrane oxygenation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 1, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Determining Cardiac Output in VA ECMO Patients

Traditional thermodilution and pulse contour analysis methods are explicitly contraindicated for measuring cardiac output during VA ECMO because the extracorporeal circuit causes systematic overestimation and produces inaccurate results; instead, use echocardiography as the primary method, supplemented by integrated hemodynamic assessment including ECMO flow monitoring, arteriovenous oxygen difference, and serial lactate measurements. 1, 2, 3

Why Traditional Methods Fail During VA ECMO

Thermodilution-Based Measurements

  • Pulmonary artery catheter (PAC) thermodilution systematically overestimates cardiac output during ECMO by a mean bias of 2.1–2.7 L/min because indicator (cold saline) is lost into the extracorporeal circuit, leading to falsely elevated readings. 3, 4
  • Transpulmonary thermodilution similarly overestimates cardiac output with a mean bias of -2.22 L/min (limits of agreement -4.18 to -0.25 L/min) compared to three-dimensional echocardiography, making it unreliable for clinical decision-making. 3
  • The degree of overestimation increases proportionally with higher ECMO flow rates, particularly when ECMO flow exceeds 50–75% of native cardiac output. 4

Pulse Contour Analysis

  • Continuous pulse contour analysis-based cardiac output monitoring is not recommended in VA ECMO patients because altered arterial waveforms from the extracorporeal circuit cause systematic underestimation of true cardiac output. 1

Recommended Methods for Cardiac Output Assessment

Primary Method: Echocardiography

  • Three-dimensional echocardiography (3D echo) is the gold standard for cardiac output measurement during VA ECMO, providing accurate assessment without interference from the extracorporeal circuit. 3
  • Repeated bedside echocardiography should be performed to assess ventricular function, loading conditions, cannula position, and to detect left ventricular overload—a specific complication of VA ECMO. 2
  • Echocardiography is particularly crucial for VA ECMO because it directly visualizes cardiac function and can identify acute cor pulmonale, which occurs in 20–25% of ARDS cases. 1

Integrated Hemodynamic Assessment

ECMO Flow Monitoring

  • Target initial ECMO flow of 3–4 L/min (approximately 60–80 mL/kg/min for adults) and record continuously throughout support. 2, 5
  • ECMO flow monitoring must be combined with other parameters to assess adequacy of support, as flow alone does not reflect native cardiac output. 5

Arteriovenous Oxygen Difference

  • Maintain arteriovenous O₂ difference of 3–5 cc O₂ per 100 mL of blood, which serves as the most reliable metric for setting ECMO flow goals and indirectly reflects the balance between total oxygen delivery and consumption. 5
  • This parameter helps determine whether ECMO flow is adequate to meet metabolic demands without directly measuring native cardiac output. 5

Mean Arterial Pressure

  • Maintain MAP ≥ 65–70 mmHg continuously using an arterial line for real-time measurement, as this reflects the combined output of native heart and ECMO circuit. 2, 5

Pulse Pressure Monitoring

  • Maintain pulse pressure > 20 mmHg within the first 24 hours, as values below this threshold are linked to acute brain injury and increased mortality in VA ECMO patients. 2
  • Low pulse pressure indicates minimal native cardiac ejection and suggests the need for left ventricular unloading strategies. 2

Metabolic and Oxygenation Markers

Central Venous Oxygen Saturation

  • Continuously monitor SvO₂ as an indicator of tissue perfusion adequacy; values > 66% suggest adequate oxygen delivery relative to consumption. 2, 5

Serial Lactate Measurements

  • Measure lactate levels serially, emphasizing absolute concentrations rather than clearance rates to gauge metabolic status and tissue perfusion. 2, 5
  • Elevated lactate may indicate inadequate ECMO flow (the most critical reversible cause of tissue hypoperfusion) or hemolysis from circuit complications. 5

Arterial Blood Gas Analysis

  • Conduct serial arterial blood gas analyses during the first 24 hours of ECMO support, obtained from a right radial arterial line to assess adequacy of oxygenation and detect differential hypoxia. 5
  • Avoid arterial hypoxemia (PaO₂ < 70 mmHg) for the first 24–48 hours to prevent hypoxic injury. 2

Specialized Monitoring for VA ECMO

Cerebral Oximetry

  • Apply continuous cerebral oximetry (regional SO₂) to all VA ECMO patients, especially those with peripheral cannulation, to detect differential hypoxia (Harlequin syndrome) promptly. 2
  • This is critical because peripheral VA ECMO can result in upper body hypoxemia if native cardiac output ejects deoxygenated blood while the ECMO circuit perfuses the lower body. 2

Critical Pitfalls to Avoid

Do Not Rely on Thermodilution-Derived Volumetric Parameters

  • Avoid using thermodilution-derived volumetric parameters (e.g., global end-diastolic volume index [GEDVI], extravascular lung water index [EVLWI]) during ECMO, as they are artificially elevated and unreliable for clinical decision-making. 2

Recognize Volume Status Clinically

  • Hypovolemia can cause venous collapse and cannula "suction" or "chatter", leading to reduced ECMO flow and hemolysis; volume status should be guided by clinical assessment, echocardiography, and fluid balance—not thermodilution. 2
  • Volume overload independently predicts adverse outcomes; accurate daily fluid-balance documentation is essential and supersedes any preload estimates derived from thermodilution. 2

Understand the Limitations of Gas Exchange Calculations

  • While experimental models suggest that the ratio of CO₂ elimination at the lung versus ECMO (V̇CO₂ECMO/V̇CO₂Lung) may reflect the ratio of respective blood flows, this approach requires normalization to ventilation-perfusion ratio of 1 and depends on steady-state conditions that are rarely achieved in clinical practice. 6
  • This method is not validated for routine clinical use and should not replace echocardiography. 6

Practical Clinical Algorithm

  1. Establish echocardiographic assessment as the primary method for cardiac output determination and repeat regularly (at least daily, more frequently if hemodynamically unstable). 2, 3

  2. Monitor ECMO circuit parameters continuously: flow rate (target 3–4 L/min), arteriovenous O₂ difference (target 3–5 cc O₂/100 mL), and MAP (≥ 65–70 mmHg). 2, 5

  3. Track metabolic markers: continuous SvO₂, serial lactate measurements, and arterial blood gases from right radial artery. 2, 5

  4. Apply VA ECMO-specific monitoring: pulse pressure (maintain > 20 mmHg) and continuous cerebral oximetry. 2

  5. Integrate all parameters to assess adequacy of support, recognizing that no single measurement of "native cardiac output" is reliable during VA ECMO; instead, the combined assessment of echocardiographic ventricular function, ECMO flow, oxygen delivery markers, and metabolic parameters guides management. 1, 2, 5

  6. Document daily fluid balance meticulously, as this is more reliable than thermodilution-derived preload estimates and independently predicts outcomes. 2

References

1
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

2
Guideline

Hemodynamic Monitoring Recommendations for ECMO Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

5
Guideline

Management of Elevated Lactate with Unwashed Blood on VA ECMO

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

In adult patients on VA or VV ECMO, should we rely on the Fick method or thermodilution to guide hemodynamic management?
What is the significance and management of shunt fraction in respiratory care?
In a non-diabetic patient with severe reactive hypoglycemia on diazoxide, how many kilograms of weight loss can be expected after three months of semaglutide titration?
How should I manage a male patient presenting with low-grade fever, dysuria, and dizziness?
Can a 69‑kg child receive the standard adult dosing of azithromycin (Zithromax)?
What oral antibiotic should be used as first‑line therapy for an uncomplicated urinary tract infection in a 76‑year‑old woman with allergies to penicillins, cephalosporins, macrolides, lincosamides, aminoglycosides, fluoroquinolones, and glycopeptides?
Is a serum potassium level of 4.1 mmol/L normal in an adult?
What is the appropriate treatment for uncomplicated urinary tract infection in a 76-year-old woman with allergies to sulfonamides, cephalexin, clindamycin, erythromycin, gentamicin, penicillins, levofloxacin, and azithromycin?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question